Advertisement
Screener

STREAMEX CORP. (STEX) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

STREAMEX CORP. Research and Development Expense

STREAMEX CORP. (STEX) reported Research and Development Expense of $31.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-05-14

  • STREAMEX CORP. research and development expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • STREAMEX CORP. research and development expense for the quarter ending 2025-09-30 was $6.00K, a 96.15% decline year-over-year.
  • STREAMEX CORP. research and development expense for the quarter ending 2025-06-30 was $19.00K, a 94.44% decline year-over-year.
  • STREAMEX CORP. research and development expense for the quarter ending 2025-03-31 was $6.00K, a 97.48% decline year-over-year.
  • STREAMEX CORP. research and development expense for fiscal 2025 was $31.00K, a 96.27% decline from fiscal 2024.
  • STREAMEX CORP. research and development expense for fiscal 2024 was $832.00K, a 83.66% decline from fiscal 2023.
  • STREAMEX CORP. research and development expense for fiscal 2023 was $5.09M, a 12.52% decline from fiscal 2022.
  • STREAMEX CORP. research and development expense for fiscal 2022 was $5.82M, a 3.91% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$6.00K
derived: sum of 2 quarters · filed 2026-03-31
$25.00K
derived: sum of 3 quarters · filed 2026-03-31
$31.00K
10-K · filed 2026-03-31
2025-09-30$6.00K
10-Q · filed 2025-11-14
$25.00K
derived: sum of 2 quarters · filed 2025-11-14
$31.00K
10-Q · filed 2025-11-14
$127.00K
derived: sum of 4 quarters · filed 2026-05-14
2025-06-30$19.00K
10-Q · filed 2025-08-15
$25.00K
10-Q · filed 2025-08-15
$121.00K
derived: sum of 3 quarters · filed 2026-05-14
$277.00K
derived: sum of 4 quarters · filed 2026-05-14
2025-03-31$6.00K
10-Q · filed 2026-05-14
$102.00K
derived: sum of 2 quarters · filed 2026-05-14
$258.00K
derived: sum of 3 quarters · filed 2026-05-14
$600.00K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$96.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$252.00K
derived: sum of 2 quarters · filed 2026-03-31
$594.00K
derived: sum of 3 quarters · filed 2026-03-31
$832.00K
10-K · filed 2026-03-31
2024-09-30$156.00K
10-Q · filed 2025-11-14
$498.00K
derived: sum of 2 quarters · filed 2025-11-14
$736.00K
10-Q · filed 2025-11-14
$1.91M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$342.00K
10-Q · filed 2025-08-15
$580.00K
10-Q · filed 2025-08-15
$1.76M
derived: sum of 3 quarters · filed 2025-08-15
$2.90M
derived: sum of 4 quarters · filed 2025-08-15
2024-03-31$238.00K
10-Q · filed 2025-05-19
$1.41M
derived: sum of 2 quarters · filed 2025-05-19
$2.56M
derived: sum of 3 quarters · filed 2025-05-19
$4.27M
derived: sum of 4 quarters · filed 2025-05-19
2023-12-31$1.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
$2.32M
derived: sum of 2 quarters · filed 2025-04-15
$4.03M
derived: sum of 3 quarters · filed 2025-04-15
$5.09M
10-K · filed 2025-04-15
2023-09-30$1.15M
10-Q · filed 2024-11-14
$2.85M
derived: sum of 2 quarters · filed 2024-11-14
$3.92M
10-Q · filed 2024-11-14
$5.04M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$1.71M
10-Q · filed 2024-08-14
$2.77M
10-Q · filed 2024-08-14
$3.89M
derived: sum of 3 quarters · filed 2024-08-14
$5.62M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$1.06M
10-Q · filed 2024-05-20
$2.18M
derived: sum of 2 quarters · filed 2024-05-20
$3.92M
derived: sum of 3 quarters · filed 2024-05-20
$5.27M
derived: sum of 4 quarters · filed 2024-05-20
2022-12-31$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$2.85M
derived: sum of 2 quarters · filed 2024-04-16
$4.20M
derived: sum of 3 quarters · filed 2024-04-16
$5.82M
10-K · filed 2024-04-16
2022-09-30$1.73M
10-Q · filed 2023-11-14
$3.08M
derived: sum of 2 quarters · filed 2023-11-14
$4.70M
10-Q · filed 2023-11-14
$6.05M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$1.35M
10-Q · filed 2023-08-14
$2.97M
10-Q · filed 2023-08-14
$4.32M
derived: sum of 3 quarters · filed 2023-08-14
$5.64M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$1.62M
10-Q · filed 2023-05-15
$2.97M
derived: sum of 2 quarters · filed 2023-05-15
$4.29M
derived: sum of 3 quarters · filed 2023-05-15
$5.95M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$1.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$2.67M
derived: sum of 2 quarters · filed 2023-03-31
$4.34M
derived: sum of 3 quarters · filed 2023-03-31
$5.60M
10-K · filed 2023-03-31
2021-09-30$1.31M
10-Q · filed 2022-11-14
$2.98M
derived: sum of 2 quarters · filed 2022-11-14
$4.25M
10-Q · filed 2022-11-14
$6.83M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$1.67M
10-Q · filed 2022-08-15
$2.93M
10-Q · filed 2022-08-15
$5.51M
derived: sum of 3 quarters · filed 2022-08-15
$10.42M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$1.27M
10-Q · filed 2022-05-16
$1.27M
10-Q · filed 2021-05-17
$3.85M
derived: sum of 2 quarters · filed 2022-05-16
$8.76M
derived: sum of 3 quarters · filed 2022-05-16
$14.47M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$2.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$7.49M
derived: sum of 2 quarters · filed 2022-03-31
$13.21M
derived: sum of 3 quarters · filed 2022-03-31
$18.14M
10-K · filed 2022-03-31
$18.14M
10-K · filed 2021-03-15
2020-09-30$4.91M
10-Q · filed 2021-11-15
$4.91M
10-Q · filed 2020-11-05
$10.63M
derived: sum of 2 quarters · filed 2021-11-15
$15.56M
10-Q · filed 2021-11-15
$15.56M
10-Q · filed 2020-11-05
$20.34M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$5.72M
10-Q · filed 2021-08-11
$5.72M
10-Q · filed 2020-08-06
$10.64M
10-Q · filed 2021-08-11
$10.64M
10-Q · filed 2020-08-06
$15.43M
derived: sum of 3 quarters · filed 2021-08-11
$17.08M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$4.93M
10-Q · filed 2021-05-17
$9.72M
derived: sum of 2 quarters · filed 2021-05-17
$11.36M
derived: sum of 3 quarters · filed 2021-05-17
$13.18M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$4.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
$6.43M
derived: sum of 2 quarters · filed 2021-03-15
$8.25M
derived: sum of 3 quarters · filed 2021-03-15
$9.74M
10-K · filed 2021-03-15
$9.74M
10-K · filed 2020-03-13
2019-09-30$1.64M
10-Q · filed 2020-11-05
$3.46M
derived: sum of 2 quarters · filed 2020-11-05
$4.95M
10-Q · filed 2020-11-05
$6.26M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$1.82M
10-Q · filed 2020-08-06
$3.31M
10-Q · filed 2020-08-06
$4.62M
derived: sum of 3 quarters · filed 2020-08-06
$5.36M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$1.49M
10-Q · filed 2020-05-11
$2.80M
derived: sum of 2 quarters · filed 2020-05-11
$3.55M
derived: sum of 3 quarters · filed 2020-05-11
$5.00M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$2.06M
derived: sum of 2 quarters · filed 2020-03-13
$3.51M
derived: sum of 3 quarters · filed 2020-03-13
$4.37M
10-K · filed 2020-03-13
2018-09-30$744.17K
10-Q · filed 2019-10-23
$2.19M
derived: sum of 2 quarters · filed 2019-10-23
$3.06M
10-Q · filed 2019-10-23
$4.01M
derived: sum of 4 quarters · filed 2019-10-23
2018-06-30$1.45M
10-Q · filed 2019-07-31
$2.31M
10-Q · filed 2019-07-31
$3.27M
derived: sum of 3 quarters · filed 2019-07-31
$4.39M
derived: sum of 4 quarters · filed 2019-07-31
2018-03-31$862.42K
10-Q · filed 2019-04-15
$1.82M
derived: sum of 2 quarters · filed 2019-04-15
$2.94M
derived: sum of 3 quarters · filed 2019-04-15
$4.28M
derived: sum of 4 quarters · filed 2019-04-15
2017-12-31$954.32K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$2.08M
derived: sum of 2 quarters · filed 2019-03-15
$3.42M
derived: sum of 3 quarters · filed 2019-03-15
$4.76M
10-K · filed 2019-03-15
2017-09-30$1.12M
10-Q · filed 2018-11-02
$2.46M
derived: sum of 2 quarters · filed 2018-11-02
$3.80M
10-Q · filed 2018-11-02
$4.32M
derived: sum of 4 quarters · filed 2018-11-02
2017-06-30$1.34M
10-Q · filed 2018-07-27
$2.68M
10-Q · filed 2018-07-27
$3.19M
derived: sum of 3 quarters · filed 2018-07-27
$3.75M
derived: sum of 4 quarters · filed 2018-07-27
2017-03-31$1.34M
10-Q · filed 2018-05-04
$1.85M
derived: sum of 2 quarters · filed 2018-05-04
$2.41M
derived: sum of 3 quarters · filed 2018-05-04
$3.57M
derived: sum of 4 quarters · filed 2018-05-04
2016-12-31$514.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$1.08M
derived: sum of 2 quarters · filed 2018-02-27
$2.23M
derived: sum of 3 quarters · filed 2018-02-27
$2.65M
10-K · filed 2018-02-27
2016-09-30$560.51K
10-Q · filed 2017-11-09
$1.71M
derived: sum of 2 quarters · filed 2017-11-09
$2.14M
10-Q · filed 2017-11-09
$2.45M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$1.15M
10-Q · filed 2017-08-10
$1.58M
10-Q · filed 2017-08-10
$1.89M
derived: sum of 3 quarters · filed 2017-08-10
$2.24M
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31$372.43K
10-Q · filed 2017-05-09
$733.30K
derived: sum of 2 quarters · filed 2017-05-09
$1.09M
derived: sum of 3 quarters · filed 2017-05-09
$1.58M
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31$360.88K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11
$715.35K
derived: sum of 2 quarters · filed 2017-04-11
$1.20M
derived: sum of 3 quarters · filed 2017-04-11
$1.51M
10-K · filed 2017-04-11
$1.24M
10-K · filed 2016-03-14
2015-09-30$354.47K
10-Q · filed 2016-11-14
$300.78K
10-Q · filed 2015-11-13
$844.03K
derived: sum of 2 quarters · filed 2016-11-14
$1.15M
10-Q · filed 2016-11-14
$931.36K
10-Q · filed 2015-11-13
$2.29M
derived: sum of 4 quarters · filed 2017-04-11
2015-06-30$489.56K
10-Q · filed 2016-08-12
$328.50K
10-Q · filed 2015-07-28
$791.64K
10-Q · filed 2016-08-12
$630.58K
10-Q · filed 2015-07-28
$1.93M
derived: sum of 3 quarters · filed 2017-04-11
$2.08M
derived: sum of 4 quarters · filed 2017-04-11
2015-03-31$302.08K
10-Q · filed 2016-05-04
$1.44M
derived: sum of 2 quarters · filed 2017-04-11
$1.59M
derived: sum of 3 quarters · filed 2017-04-11
$1.69M
derived: sum of 4 quarters · filed 2017-04-11
2014-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11
$1.28M
derived: sum of 2 quarters · filed 2017-04-11
$1.38M
derived: sum of 3 quarters · filed 2017-04-11
$1.51M
10-K · filed 2017-04-11
$548.00K
10-K · filed 2015-02-20
2014-09-30$144.23K
10-Q · filed 2015-11-13
$244.12K
derived: sum of 2 quarters · filed 2015-11-13
$366.27K
10-Q · filed 2015-11-13
$583.67K
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30$99.89K
10-Q · filed 2015-07-28
$222.04K
10-Q · filed 2015-07-28
$439.44K
derived: sum of 3 quarters · filed 2015-07-28
$729.40K
derived: sum of 4 quarters · filed 2015-07-28
2014-03-31$122.15K
10-Q · filed 2015-05-01
$339.55K
derived: sum of 2 quarters · filed 2015-05-01
$629.51K
derived: sum of 3 quarters · filed 2015-05-01
$808.02K
derived: sum of 4 quarters · filed 2015-05-01
2013-12-31$217.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20
$507.36K
derived: sum of 2 quarters · filed 2015-02-20
$685.87K
derived: sum of 3 quarters · filed 2015-02-20
$992.21K
10-K · filed 2015-02-20
2013-09-30$289.96K
10-Q · filed 2014-10-17
$468.47K
derived: sum of 2 quarters · filed 2014-10-17
$774.81K
10-Q · filed 2014-10-17
2013-06-30$178.51K
10-Q · filed 2014-07-28
$484.85K
10-Q · filed 2014-07-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B